|
It's a good idea that has been around for a while where you take a patient's cell and re-engineer them to produce a modified, repaired, or improved protein. In this case you would make your T-cells attack and target cancer cells for degradation without touching the normal tissue.
Genetic engineering, treatment would likely be prohibitively expensive.
Better wait for some phase I or II, I agree.
|